These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36083096)

  • 21. Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy.
    Foxall R; Narang P; Glaysher B; Hub E; Teal E; Coles MC; Ashton-Key M; Beers SA; Cragg MS
    Front Immunol; 2020; 11():605231. PubMed ID: 33628205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?
    Hoarau-Véchot J; Rafii A; Touboul C; Pasquier J
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29346265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microfluidic modeling of the biophysical microenvironment in tumor cell invasion.
    Huang YL; Segall JE; Wu M
    Lab Chip; 2017 Sep; 17(19):3221-3233. PubMed ID: 28805874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Modeling-on-a-Chip with Future Artificial Intelligence Integration.
    Fetah KL; DiPardo BJ; Kongadzem EM; Tomlinson JS; Elzagheid A; Elmusrati M; Khademhosseini A; Ashammakhi N
    Small; 2019 Dec; 15(50):e1901985. PubMed ID: 31724305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models.
    Ringquist R; Ghoshal D; Jain R; Roy K
    Adv Drug Deliv Rev; 2021 Dec; 179():114003. PubMed ID: 34653533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in spheroid-based microfluidic models to mimic the tumour microenvironment.
    Ro J; Kim J; Cho YK
    Analyst; 2022 May; 147(10):2023-2034. PubMed ID: 35485712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The updated landscape of tumor microenvironment and drug repurposing.
    Jin MZ; Jin WL
    Signal Transduct Target Ther; 2020 Aug; 5(1):166. PubMed ID: 32843638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.
    Amirghasemi F; Adjei-Sowah E; Pockaj BA; Nikkhah M
    Ann Biomed Eng; 2021 Aug; 49(8):1943-1972. PubMed ID: 33403451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy.
    Deep G; Agarwal R
    Curr Cancer Drug Targets; 2013 Jun; 13(5):486-99. PubMed ID: 23617249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complex interplay between tumor microenvironment and cancer therapy.
    Shen M; Kang Y
    Front Med; 2018 Aug; 12(4):426-439. PubMed ID: 30097962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
    Jena BC; Mandal M
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
    Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
    Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent research advances of the biomimetic tumor microenvironment and regulatory factors on microfluidic devices: A systematic review.
    Xu H; Cheng C; Le W
    Electrophoresis; 2022 Apr; 43(7-8):839-847. PubMed ID: 35179796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling.
    Heninger E; Kosoff D; Rodems TS; Sethakorn N; Singh A; Gungurthi H; Carlson KN; Yang B; Gilsdorf C; Pasch CA; Deming DA; Ellis L; Beebe DJ; Jarrard DF; Lang JM
    Med Oncol; 2021 Sep; 38(11):135. PubMed ID: 34581895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paper/PMMA Hybrid 3D Cell Culture Microfluidic Platform for the Study of Cellular Crosstalk.
    Lei KF; Chang CH; Chen MJ
    ACS Appl Mater Interfaces; 2017 Apr; 9(15):13092-13101. PubMed ID: 28353331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-macrophage crosstalk: how to listen.
    Dey T
    Integr Biol (Camb); 2020 Dec; 12(12):291-302. PubMed ID: 33210118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
    Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
    Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascularized microfluidic platforms to mimic the tumor microenvironment.
    Michna R; Gadde M; Ozkan A; DeWitt M; Rylander M
    Biotechnol Bioeng; 2018 Nov; 115(11):2793-2806. PubMed ID: 29940072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imitating Hypoxia and Tumor Microenvironment with Immune Evasion by Employing Three Dimensional
    Ray SK; Mukherjee S
    Recent Pat Anticancer Drug Discov; 2022; 17(1):80-91. PubMed ID: 34323197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.